This work was aimed to clarify, whether efavirenz induces ABC-transporters in vivo in PBMCs and whether possible changes in PBMC transporter expression also translate into altered intracellular concentrations of efavirenz. New analytical methods for quantification of efavirenz in plasma, plasma ultrafiltrate and PBMCs were developed.
The samples were analyzed by LC/MS/MS.